scispace - formally typeset
J

J. Frank Nash

Researcher at Procter & Gamble

Publications -  37
Citations -  2352

J. Frank Nash is an academic researcher from Procter & Gamble. The author has contributed to research in topics: MDMA & Dopamine. The author has an hindex of 23, co-authored 35 publications receiving 2249 citations. Previous affiliations of J. Frank Nash include Case Western Reserve University.

Papers
More filters
Journal ArticleDOI

Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

TL;DR: Data are suggestive that the long-term (7 day) DA neurotoxicity produced by the repeated administration of MA is mediated, in part, by a delayed increase in extracellular concentrations of GLU.
Journal ArticleDOI

Human safety review of “nano” titanium dioxide and zinc oxide

TL;DR: The public health benefits of sunscreens containing nano TiO(2) and/or ZnO outweigh human safety concerns for these UV filters, and the in vitro genotoxic and photogenotoxic profiles of these nano-structured metal oxides are of no consequence to human health.
Journal ArticleDOI

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

TL;DR: In vivo microdialysis data are supportive of a state‐dependent, stimulatory role of 5‐HT in the regulation of dopamine release, and are consistent with the view that MDMA increases the extracellular concentration of 4,4‐methylenedioxymethamphetamine by facilitating carrier‐mediated 5‐ HT release, which can be enhanced greatly under conditions in which5‐HT synthesis is stimulated.
Journal ArticleDOI

In vitro assessment of the broad-spectrum ultraviolet protection of sunscreen products

TL;DR: Determination of critical wavelength by means of UV substrate spectrophotometry provides a rapid, inexpensive, and reliable measure of broad-spectrum protection, which is largely independent of SPF, yet ensures long-wavelength UVA protection commensurate with SPF.
Journal ArticleDOI

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

TL;DR: It is concluded that activation of 5- HT2 receptors is an important determinant of the acute increase in extracellular dopamine and, consequently, the long-term depletion of brain 5-HT produced by MDMA.